Adhesion molecules as a prognostic marker of liver cirrhosis

References

• Navasa M, Rimola A, Rodés J. Bacterial infections in liver disease. Semin Liver Dis 1997;17:323–33.
   PubMed Web of Science ®Google Scholar
• Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264–74.
   PubMed Web of Science ®Google Scholar
• Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003;37:208–17.
   PubMed Web of Science ®Google Scholar
• Borrelli E, Roux-Lombard P, Grau GE, Ricou B, Dayer J, Suter PM. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996;24:392–7.
   PubMed Web of Science ®Google Scholar
• Zeni F, Tardy B, Vindimian M, Comtet C, Page Y, Cusey I, et al. High levels of tumor necrosis factor-a and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993;17:218–23.
   PubMed Web of Science ®Google Scholar
• Propst T, Propst A, Herold M, Schauer G, Judmaier G, Braunsteiner H, et al. Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid. Eur J Clin Invest 1993;23:832–6.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Ramos C, Galán F, Díaz F, Elvira J, Martín-Herrera L, Girón-González JA. Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci 2001;46: 1668–76.
   PubMed Web of Science ®Google Scholar
• Girón-González JA, Martínez-Sierra C, Rodríguez-Ramos C, Macias MA, Rendón P, Fernández C, et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 2004;24:437–45.
   PubMed Web of Science ®Google Scholar
• Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068–101.
   PubMed Web of Science ®Google Scholar
• Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147:3788–93.
   PubMed Web of Science ®Google Scholar
• Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992;187:584–9.
   PubMed Web of Science ®Google Scholar
• Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, et al. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrosis. Am J Gastroenterol 1999;94:169–77.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151–7.
   Google Scholar
• Porcel A, Díaz F, Rendón P, Macías M, Martín-Herrera L, Girón-González JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162: 323–8.
   PubMedGoogle Scholar
• Girón-González JA, Rodríguez-Ramos C, Elvira J, Galán F, Fernández-Gutiérrez del Álamo C, Díaz F, et al. Serial analysis of serum and ascitic fluid levels of soluble adhesion molecules and chemokines in patients with spontaneous bacterial peritonitis. Clin Exp Immunol 2001;123:56–61.
   Google Scholar
• Ginés A, Escorsell A, Ginés P, Salo J, Jimenez W, Inglada L, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 1993;105:229–36.
   Google Scholar
• Arroyo V, Ginés P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164–76.
   PubMed Web of Science ®Google Scholar
• Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000;32:142–53.
   PubMed Web of Science ®Google Scholar
• de Franchis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutics strategies in portal hypertension. J Hepatol 2000;33:846–52.
   PubMed Web of Science ®Google Scholar
• Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in cirrhosis: report on the Conference of the International Ascites Club. Hepatology 2003;38:258–66.
   PubMed Web of Science ®Google Scholar
• Solis-Herruzo JA, Gómez-Gamarra A, Castellano G, Muñoz-Yagüe MT. Metabolic clearance rate of arginine vasopressin in patients with cirrhosis. Hepatology 1992;16:974–9.
   PubMed Web of Science ®Google Scholar
• Elizalde JI, Moitinho E, García-Pagán JC, Cirera I, Escorsell A, Bandi JC, et al. Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients. J Hepatol 1998;29:789–95.
   Google Scholar
• Hadengue A, Gadano A, Moreau R, Giostra E, Durand F, Valla D, et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 1998;29:565–70.
   PubMed Web of Science ®Google Scholar
• Andus T, Gross V, Holstege A, Weber M, Ott M, Gerok W, et al. Evidence for the production of high amounts of interleukin-6 in the peritoneal cavity of patients with ascites. J Hepatol 1992;15:378–81.
   PubMed Web of Science ®Google Scholar
• Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992;13:151–3.
   PubMedGoogle Scholar
• Díez-Ruiz A, Tiltz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnostics. Eur J Haematol 1995;54:1–8.
   Google Scholar
• Naveau S, Abella A, Raynard B, Balian A, Giraud V, Montembault S, et al. Tumor necrosis factor soluble receptor p55 and lipid peroxidation in patients with acute alcoholic hepatitis. Am J Gastroenterol 2001;96:3361–7.
   PubMed Web of Science ®Google Scholar
• Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL. Cytokines and cytokine receptors in advanced heart failure. Circulation 2001;103:2055–9.
   PubMed Web of Science ®Google Scholar
• Spitzer JA. Cytokine stimulation of nitric oxide formation and differential regulation in hepatocytes and nonparenchymal cells of endotoxemic rats. Hepatology 1994;19:217–28.
   PubMed Web of Science ®Google Scholar
• Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology 1994;20: 1343–50.
   PubMed Web of Science ®Google Scholar
• García-Tsao G, Angulo P, Garcia JC, Groszman RJ, Cadelina GW. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis. Hepatology 1998;28:17–21.
   Google Scholar
• Llach J, Ginés P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988;94:482–7.
   PubMed Web of Science ®Google Scholar
• Abad-Lacruz A, Cabré E, González-Huix F, Fernandez- Banares F, Esteve M, Planas R, et al. Routine test of renal function, alcoholism, and nutrition improve the prognosis accuracy of Child-Pugh score in nonbleeding advanced cirrhosis. Am J Gastroenterol 1993;88:382–7.
   PubMed Web of Science ®Google Scholar
• Zeni F, Tardy B, Vindimian M, Comtet C, Page Y, Cusey I, et al. High levels of tumor necrosis factor-α and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis. Clin Infect Dis 1993;17:218–23.
   PubMed Web of Science ®Google Scholar
• Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998;27:1227–32.
   PubMed Web of Science ®Google Scholar
• Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome and multiple organ dysfunction syndrome. Ann Intern Med 1996;125:680–7.
   PubMed Web of Science ®Google Scholar
• Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771–8.
   Google Scholar
• Dinarello CA. Proinflammatory cytokines. Chest 2000;118: 503–8.
   PubMed Web of Science ®Google Scholar
• Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993;21: S423–35.
   PubMed Web of Science ®Google Scholar
• Barton RW, Rothlein R, Ksiazek J, Kennedy C. The effect of intercellular adhesion molecules-1 on phorbol-ester- induced rabbit lung inflammation. J Immunol 1989;143: 1278–82.
   PubMed Web of Science ®Google Scholar